Tag: Pharmaceutical Deal

Rentschler Biopharma buys US manufacturing facility from Shire

Rentschler Biopharma, a leading contract development and manufacturing organization for biopharmaceuticals, has signed an agreement to purchase a manufacturing facility from an affiliate Shire.

Trimb Healthcare acquires BioClin BV

Trimb Healthcare (Sweden) has completed the acquisition of BioClin BV, a leading intimate healthcare company based in Delft (Netherlands).

Biotage acquires new technology platform suited for biopharma industry

Biotage AB, a global life science company, has entered into an agreement to acquire the privately held company PhyNexus (California, USA) for a total purchase price of $21.5 million.

AGC buys API manufacturer from Boehringer Ingelheim

AGC, a world-leading manufacturer of glass, chemicals and high-tech materials, has announced that it has entered into an agreement with Boehringer Ingelheim to acquire Malgrat Pharma Chemicals.

Janssen signs collaboration and license agreement with Dutch biotech

drug discovery
argenx, a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies announced an exclusive agreement with Janssen.

GSK acquires promising biopharma company Tesaro

GlaxoSmithKline announced that it will acquire TESARO, an oncology-focused company for an aggregate cash consideration of approximately $5.1 billion.

Genentech obtains rights to preclinical portfolio of Jecure Therapeutics

drug discovery
Jecure Therapeutics, a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, announced it will be acquired by Genentech, a member of the Roche Group.

Telix Pharmaceuticals buys Advanced Nuclear Medicine Ingredients

Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company, has announced the acquisition of Belgium-based Advanced Nuclear Medicine Ingredients (ANMI).

Sun Pharma to acquire Japanese drug manufacturer

sun pharma
Sun Pharma announced it has entered into a agreement to acquire Pola Pharma, a company engaged in research and development, manufacture, sale and distribution of branded and generic products.

MorphoSys signed agreement with I-Mab for a novel immuno-oncology agent

MorphoSys and I-Mab Biopharma, a biotech company focused on onimmuno-oncology and autoimmune diseases, jointly announced that they have entered into an exclusive strategic collaboration

Grünenthal buys US pharma company Averitas Pharma

Grünenthal, a German research-based pharmaceutical company focused on pain treatment products, announced that it has acquired the US-based pharmaceutical company Averitas Pharma.

Hikma Pharmaceuticals acquires Medlac Pharma Italy

Hikma Pharmaceuticals entered into an agreement to acquire 100 per cent of the share capital of Medlac Pharma Italy, an injectable manufacturing company in Vietnam.

RCIF and AFK Sistema invest 19 billion rubles in ‘Obolenskoye’ pharma holding

The Russia-China Investment Fund (RCIF) and AFK Sistema have agreed to establish a leading pharmaceutical company in Russia with a total investment of over 19 billion rubles.

BioTime aimed to become a premier cellular therapy company

BioTime and Asterias Biotherapeutics announced that they have entered into a definitive merger agreement whereby BioTime will acquire all of the remaining outstanding common stock of Asterias.

Sygnature Discovery signs drug discovery deal with Sitryx Therapeutics

Sygnature Discovery announced a multi-target, integrated drug discovery collaboration with Sitryx Therapeutics to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation.

AstraZeneca sells its rights for three corticosteroid drugs to Covis Pharma

AstraZeneca has entered into an agreement with Covis Pharma B.V. (Switzerland) to sell its rights to the medicines Alvesco (ciclesonide), and Omnaris and Zetonna (ciclesonide).